Brain stimulation was safe for cannabis craving but adding visual cannabis cues did not improve results

High-definition transcranial direct current stimulation showed promise for reducing cannabis craving, but combining it with cannabis cue exposure did not add benefit over stimulation alone.

Chauhan, Devika et al.·The journal of ECT·2025·Preliminary EvidenceRandomized Controlled Trial
RTHC-06189Randomized Controlled TrialPreliminary Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Randomized Controlled Trial
Evidence
Preliminary Evidence
Sample
N=48

What This Study Found

All groups showed reduced cannabis craving, frequency, and improved cognition; anodal right DLPFC HD-tDCS was safe with high completion rates (91.7%); cue exposure did not add to the effect of stimulation.

Key Numbers

48 participants; 4 groups of 12; 19.6% acceptance rate; 91.7% completion rate; craving reductions sustained at 4-week follow-up in all groups except sham + cue; cannabis use frequency and amount reduced in all groups.

How They Did This

Double-blind RCT; 48 participants with cannabis use disorder randomized to 4 groups (tDCS + cue, tDCS + neutral, sham + cue, sham + neutral); 6 sessions; craving assessed post-treatment and at 4-week follow-up.

Why This Research Matters

Non-invasive brain stimulation represents a potential medication-free treatment for cannabis use disorder, though optimal protocols still need refinement.

The Bigger Picture

Brain stimulation therapies for substance use disorders are advancing, and this pilot suggests tDCS targeting the right DLPFC is safe and feasible for cannabis use disorder.

What This Study Doesn't Tell Us

Small sample (48 total, 12 per group); low acceptance rate (19.6%); all groups improved, making it difficult to isolate specific effects; no long-term follow-up beyond 4 weeks.

Questions This Raises

  • ?Why did sham groups also improve?
  • ?Would more sessions or different stimulation parameters produce stronger between-group differences?
  • ?Can acceptance rates be improved for clinical translation?

Trust & Context

Key Stat:
91.7% completion rate but only 19.6% of eligible patients agreed to participate
Evidence Grade:
Randomized double-blind design provides methodological rigor, but small sample size and improvements across all groups (including sham) limit conclusions about specific efficacy.
Study Age:
Published 2025
Original Title:
Acceptability, Feasibility, and Effectiveness of Concurrent High-Definition Transcranial Direct Current Stimulation and Cue Exposure in Cannabis Use Disorder: A Pilot Double-Blind Randomized Controlled Trial.
Published In:
The journal of ECT, 41(2), 126-135 (2025)
Database ID:
RTHC-06189

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled TrialGold standard for testing treatments
This study
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal Study

Participants are randomly assigned to treatment or placebo groups to test cause and effect.

What do these levels mean? →

Frequently Asked Questions

Did brain stimulation reduce cannabis craving?

All groups showed craving reductions, including sham groups, making it difficult to attribute effects specifically to stimulation versus other factors like study participation.

Was the treatment safe?

Yes. Adverse effects and dropout rates did not differ between active and sham stimulation groups, and 91.7% of enrolled participants completed all sessions.

Read More on RethinkTHC

Cite This Study

RTHC-06189·https://rethinkthc.com/research/RTHC-06189

APA

Chauhan, Devika; Ghosh, Abhishek; Naik, Shalini S; Rana, Devender K; Singh, Shubh Mohan. (2025). Acceptability, Feasibility, and Effectiveness of Concurrent High-Definition Transcranial Direct Current Stimulation and Cue Exposure in Cannabis Use Disorder: A Pilot Double-Blind Randomized Controlled Trial.. The journal of ECT, 41(2), 126-135. https://doi.org/10.1097/YCT.0000000000001087

MLA

Chauhan, Devika, et al. "Acceptability, Feasibility, and Effectiveness of Concurrent High-Definition Transcranial Direct Current Stimulation and Cue Exposure in Cannabis Use Disorder: A Pilot Double-Blind Randomized Controlled Trial.." The journal of ECT, 2025. https://doi.org/10.1097/YCT.0000000000001087

RethinkTHC

RethinkTHC Research Database. "Acceptability, Feasibility, and Effectiveness of Concurrent ..." RTHC-06189. Retrieved from https://rethinkthc.com/research/chauhan-2025-acceptability-feasibility-and-effectiveness

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.